Back to search

New Path Molecular Research Ltd

09412383

active
Private Limited Company
england wales
Companies House
1 outstanding charge
Health Score
78 / 100

Some Concerns

30/30
Filing
10/30
Financial
38/40
Risk
  • Current liabilities exceed current assets (-10)
  • 1 outstanding charge (-2)

Details

BUILDING 580, CAMBRIDGE, CB22 3AT
Incorporated 29/01/2015

Compliance

Last accounts

31/05/2025

micro entity

Next accounts due

28/02/2027

On track

Confirmation statement

Last: 29/01/2026

Due 12/02/2027

On track

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Elizabeth Farrant

director · Since 29/01/2015

DIRECTOR

BRITISH · ENGLAND · Age 56

Mr Andrew Wilson Maccormack

director · Since 07/05/2015

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 61

Also on 14 other boards

Dr Nikzad Nikbin-Roudsari

director · Since 07/05/2015

SCIENTIST

BRITISH · UNITED KINGDOM · Age 55

Also on 1 other board

Ms Beatrice Katherine Leigh

director · Since 15/05/2017

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM · Age 74

Also on 1 other board

Deepbridge Ned Limited

director · Since 13/02/2024

Also on 21 other boards

Persons with Significant Control

Professor Steven Victor Ley

25–50% shares

British · England · Age 80

Building 580, Babraham Research Campus, Cambridge, CB22 3AT

Notified 06/04/2016

Charges1 outstanding

A registered charge
outstanding

Sprk Capital Limited

Created 14/08/2026Registered 14/08/2026

CompanyRankvs 385+ SIC 72190 peers
73

Financial strength87th percentile among SIC peers · 22/25
Employees90th percentile among SIC peers · 14/15
LiquidityCurrent ratio 3.4× · 20/20
Longevity12 years trading (max 15) · 12/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Kemet International Limited
90
2R.B. Radley & Company Limited
90
3Drumgrange Limited
90
4Giro Engineering Limited
90
5Hydronix Limited
90
6Fluid Gravity Engineering Limited
90
7Innovative Technology Limited
90
8Scanna Msc Limited
90
9Euclid Limited
90
10Secure Innovation Limited
90
385New Path Molecular Research Ltd
82
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity12/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/05/2025

Net Worth

£254k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£272k

Working capital

Current Assets

£286k

Current Liabilities

£84k

Fixed Assets

£8k

6avg. employees+1

Balance Sheet

Assets less current liabilities£279k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20253.40-£27k
20242.72+£168k
20232.60—

Derived from filed accounts. Not audited figures.